Wan J, Zhang ZC, Yang MQ, Sun XM, Yin L, Chen CQ. Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report. World J Clin Cases 2021; 9(17): 4342-4347 [PMID: 34141799 DOI: 10.12998/wjcc.v9.i17.4342]
Corresponding Author of This Article
Chun-Qiu Chen, MD, Chief Doctor, Center for Difficult and Complicated Abdominal Surgery, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai 200072, China. chenchunqiu6@126.com
Research Domain of This Article
Surgery
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Jian Wan, Zi-Chao Zhang, Mu-Qing Yang, Lu Yin, Chun-Qiu Chen, Center for Difficult and Complicated Abdominal Surgery, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China
Xiao-Min Sun, Department of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China
Author contributions: Wan J reviewed the literature and drafted the manuscript; Wan J, Zhang ZC, Yang MQ, Yin L and Chen CQ performed the surgery; Chen CQ and Sun XM revised the manuscript; All authors have approved the submission of this manuscript.
Informed consent statement: The images and clinical data included in the articles were obtained with the patient’s written informed consent.
Conflict-of-interest statement: The authors declare that there is no conflict of interest regarding the publication of this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chun-Qiu Chen, MD, Chief Doctor, Center for Difficult and Complicated Abdominal Surgery, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai 200072, China. chenchunqiu6@126.com
Received: February 12, 2021 Peer-review started: February 12, 2021 First decision: March 14, 2021 Revised: March 22, 2021 Accepted: March 25, 2021 Article in press: March 25, 2021 Published online: June 16, 2021 Processing time: 102 Days and 19.1 Hours
Abstract
BACKGROUND
Inflammatory bowel disease (IBD) is rare in patients with glycogen storage disease (GSD). In GSD patients, a decrease in the number of neutrophils leads to prolonged intestinal infection, leading to the formation of chronic inflammation and eventually the development of IBD. Minimally invasive surgery for patients with IBD has been proven to reduce inflammatory responses and postoperative risks and ultimately promote rapid recovery. Herein we discuss minimally invasive surgery and the perioperative management in a patient with GSD and IBD.
CASE SUMMARY
A 23-year-old male had GSD Ib associated with IBD-like disease for 10 years. Despite standard treatments, such as mesalazine, prednisone and adalimumab, the patient eventually developed colonic stenosis with incomplete ileus. After adequate assessment, the patient was treated with minimally invasive surgery and discharged in stable condition.
CONCLUSION
Minimally invasive surgery for patients with IBD and GSD is safe, feasible and effective.
Core Tip: With progression of inflammatory bowel disease (IBD), 70% of the patients undergo at least one surgical treatment in their lifetime, which can negatively impact physical and mental health. Glycogen storage disease is a rare genetic disease. Neutropenia in such patients leads to prolonged intestinal infections and chronic inflammation, eventually progressing to IBD. Minimally invasive surgery for IBD has the advantages of fewer injuries, less pain, more rapid recovery of gastrointestinal function and a shorter postoperative hospital stay. Specifically, minimally invasive surgery has obvious advantages for patients with glycogen storage disease and IBD due to impaired autoimmune function.
